Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (''Listing Regulations''), we wish to inform ....
Awaiting price reaction for this filing.
Garodia Chemicals' board approved the audited financial results for Q4 and FY ended March 31, 2025, along with re-designating three directors as Independent Directors. The company's results show zero revenue from operations for the second consecutive year, with a net loss of ₹20.77 lakhs in FY25 (wider than ₹13.11 lakhs in FY24). Total expenses rose to ₹20.77 lakhs against nil income. Crucially, the auditor (Laxmikant Kabra & Co LLP) has flagged that the financial statements are NOT prepared on a going concern basis because management has decided to cease business operations. The company's total equity is deeply negative at ₹(469.71) lakhs, with borrowings of ₹481.87 lakhs against total assets of just ₹13.95 lakhs. Operating cash flow was negative at ₹(28.53) lakhs, funded entirely by new borrowings of ₹31.41 lakhs.
This is a severe negative signal for shareholders. The company is effectively winding down — management has formally decided to stop business, equity is fully eroded, and the business is being kept alive only through new debt. While the auditor gave an unmodified opinion, they explicitly highlighted the going concern breakdown as an emphasis matter. Shareholders face a real risk of total loss unless a revival or restructuring plan emerges.